Anthera Pharmaceuticals Inc. is a Biopharmaceutical Company focusing on developing and commercializing products to treat serious diseases associated with inflammation including cardiovascular and autoimmune diseases.


Updates from The Motley Fool

Latest updates on Anthera Pharmaceuticals from Fool.com.


Stock Performance

View Interactive ANTH Charts
Sponsored by

Key Data Points

Primary metrics and data points about Anthera Pharmaceuticals.
Current Price: $0.65
Prev Close: $0.66
Open: $0.67
Bid: $0.65
Ask: $0.66
Day's Range: $0.62 - $0.68
52wk Range: $0.51 - $4.90
Volume: 774,901
Avg Vol 1,314,160
Market Cap: $26M
P/E (ttm): -0.46
EPS (ttm): ($1.43)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Anthera Pharmaceuticals.
CAPS Rating 2 out of 5
 
81 Outperform
8 Underperform
CAPS All Stars
 
10 Outperform
2 Underperform

How do you think Anthera Pharmaceuticals will perform against the market?



You pick for Anthera Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paul F. Truex, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Anthera Pharmaceuticals.

Anthera Pharmaceuticals Inc. is a Biopharmaceutical Company focusing on developing and commercializing products to treat serious diseases associated with inflammation including cardiovascular and autoimmune diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers